Cigna Group $CI Holdings Lifted by NewEdge Advisors LLC

NewEdge Advisors LLC boosted its holdings in shares of Cigna Group (NYSE:CI) by 47.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,277 shares of the health services provider’s stock after buying an additional 11,085 shares during the period. NewEdge Advisors LLC’s holdings in Cigna Group were worth $9,143,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the business. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group in the fourth quarter worth approximately $25,000. Kemnay Advisory Services Inc. acquired a new position in Cigna Group in the 4th quarter valued at approximately $29,000. Prosperity Bancshares Inc purchased a new stake in Cigna Group in the 4th quarter worth approximately $29,000. Cedar Mountain Advisors LLC lifted its position in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after buying an additional 68 shares in the last quarter. Finally, Creative Financial Designs Inc. ADV boosted its stake in shares of Cigna Group by 147.3% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after buying an additional 81 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

CI opened at $281.95 on Monday. The company has a market cap of $74.50 billion, a PE ratio of 11.67, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29. The stock has a 50-day moving average of $286.00 and a 200-day moving average of $281.26. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm’s revenue was up 6.7% compared to the same quarter last year. During the same period last year, the business earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Analysts Set New Price Targets

CI has been the topic of a number of research reports. Morgan Stanley upped their price target on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 20th. Robert W. Baird set a $362.00 target price on Cigna Group in a research note on Friday, July 31st. Mizuho upped their target price on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, Wells Fargo & Company lifted their price target on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $339.45.

Insider Buying and Selling

In related news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 222,213 shares of company stock worth $64,751,950 in the last quarter. 0.60% of the stock is currently owned by company insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.